DBV Technologies (DBVT) Other Non-Current Assets (2014 - 2026)
DBV Technologies (DBVT) reported Other Non-Current Assets of $5.4 million for Q1 2026, up 8.87% year-over-year from $5.0 million in Q1 2025, and down 6.9% on a QoQ basis from $5.8 million in Q4 2025.
DBV Technologies (DBVT) has 13 years of Other Non-Current Assets data on file, last reported at $5.4 million in Q1 2026.
- Quarterly Other Non-Current Assets rose 8.87% year-over-year to $5.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.4 million (up 8.87% YoY) and the FY2025 annual result came in at $5.8 million, up 31.13% from the prior year.
- Other Non-Current Assets fell to $5.4 million in Q1 2026 per DBVT's latest filing, from $5.8 million in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $6.8 million in Q1 2024 and bottomed at $4.4 million in Q4 2024.
- The 5-year median for Other Non-Current Assets is $5.8 million (2023), against an average of $5.7 million.
- The widest annual swing landed in 2022, when Other Non-Current Assets plunged 84.03%; it then soared 31.13% in 2025.
- Tracing DBVT's Other Non-Current Assets over 5 years: stood at $5.8 million in 2022, then rose by 5.49% to $6.1 million in 2023, then dropped by 28.01% to $4.4 million in 2024, then soared by 31.13% to $5.8 million in 2025, then decreased by 6.9% to $5.4 million in 2026.
- Per Business Quant, the three latest DBVT Other Non-Current Assets figures stand at $5.4 million (Q1 2026), $5.8 million (Q4 2025), and $5.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 12.40 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 60,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.26 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 2.13 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 63.55 Mn |
| 10 | DBV Technologies | 8.00 Bn | 7.77 Bn | -3.90 Mn | 5.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.40 Mn |
| Dec 31, 2025 | 5.80 Mn |
| Sep 30, 2025 | 5.46 Mn |
| Jun 30, 2025 | 5.33 Mn |
| Mar 31, 2025 | 4.96 Mn |
| Dec 31, 2024 | 4.42 Mn |
| Sep 30, 2024 | 5.28 Mn |
| Jun 30, 2024 | 5.35 Mn |
| Mar 31, 2024 | 6.82 Mn |
| Dec 31, 2023 | 6.14 Mn |
| Sep 30, 2023 | 5.97 Mn |
| Jun 30, 2023 | 5.94 Mn |
| Mar 31, 2023 | 5.77 Mn |
| Dec 31, 2022 | 5.82 Mn |
| Sep 30, 2022 | 5.37 Mn |
| Jun 30, 2022 | 6.19 Mn |
| Mar 31, 2022 | 6.58 Mn |
| Dec 31, 2021 | 6.83 Mn |
| Sep 30, 2021 | 33.61 Mn |
| Jun 30, 2021 | 32.76 Mn |
| Mar 31, 2021 | 30.87 Mn |
| Dec 31, 2020 | 29.94 Mn |
| Jun 30, 2020 | 23.24 Mn |
| Dec 31, 2019 | 18.25 Mn |
| Sep 30, 2019 | 16.14 Mn |
| Jun 30, 2019 | 6.90 Mn |
| Dec 31, 2018 | 6.89 Mn |
| Jun 30, 2018 | 3.04 Mn |
| Dec 31, 2017 | 3.55 Mn |
| Jun 30, 2017 | 3.29 Mn |
| Dec 31, 2016 | 2.96 Mn |
| Jun 30, 2016 | 3.09 Mn |
| Dec 31, 2015 | 2.97 Mn |
| Jun 30, 2015 | 2.21 Mn |
| Dec 31, 2014 | 1.99 Mn |